English中文

Offstream
news


COVID-19 pandemic

Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine.

Sources:  Bloomberg


Changes

  1. Polish biotechnology company Mabion S.A. signs an agreement with Novavax to start its commercial-scale production trials with U.S. pharmaceutical company for its future vaccine.
  2. Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine.

Related